Share on LinkedInShare on LinkedIn

ARTICLE · 26 OCTOBER 2022

Patent Linkage In Indonesia

The regulations support the existence of patent linkage in Indonesia. Generic drug approval is therefore subject to patents that are notified to the BPOM.

IndonesiaIntellectual Property

Kin Wah, Evi and Mayang discuss the implementation of regulations supporting patent linkage in Indonesia.

The regulations support the existence of patent linkage in Indonesia. Generic drug approval is therefore subject to patents that are notified to the BPOM. BPOM means Badan Pengawas Obat dan Makanan (National Agency of Drug and Food Control). We discuss below implementation of relevant regulations.

Introduction

Patent linkages are understood to mean the practice of national drug approval agencies “linking” the granting of marketing approval with the patent status of the originator drug. By this definition, patent linkage can be said to be implemented by BPOM based on current practice.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from